25 XP   0   0   10

Shanxi C&Y Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Shanxi C&Y Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Shanxi C&Y Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanxi C&Y Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shanxi C&Y Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Shanxi C&Y Pharmaceutical Group Co Ltd.

Quick analysis of Shanxi C&Y Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Shanxi C&Y Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥3.22
Expected worth in 1 year
¥3.42
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
¥0.26
Return On Investment
3.1%

For what price can you sell your share?

Current Price per Share
¥8.18
Expected price per share
¥4.98 - ¥11.60
How sure are you?
50%

1. Valuation of Shanxi C&Y Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.18

Intrinsic Value Per Share

¥-3.86 - ¥8.71

Total Value Per Share

¥-0.64 - ¥11.93

2. Growth of Shanxi C&Y Pharmaceutical Group Co Ltd (5 min.)




Is Shanxi C&Y Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$107.5m$107.4m-$5.4m-5.4%

How much money is Shanxi C&Y Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$869.8k-$4m$4.9m570.6%
Net Profit Margin2.2%-14.9%--

How much money comes from the company's main activities?

3. Financial Health of Shanxi C&Y Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Shanxi C&Y Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Shanxi C&Y Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Shanxi C&Y Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Shanxi C&Y Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Shanxi C&Y Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shanxi C&Y Pharmaceutical Group Co Ltd is ¥8.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanxi C&Y Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanxi C&Y Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.22. Based on the TTM, the Book Value Change Per Share is ¥0.05 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanxi C&Y Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.3%0.000.0%-0.01-0.1%-0.01-0.1%0.000.0%
Usd Book Value Change Per Share0.030.3%0.010.1%0.000.0%0.00-0.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.1%
Usd Total Gains Per Share0.030.4%0.010.1%0.000.0%0.000.0%0.010.1%
Usd Price Per Share1.33-1.11-1.05-1.05-1.92-
Price to Earnings Ratio14.96-6.55--142.99--13.75-80.44-
Price-to-Total Gains Ratio45.24-72.55-328.29-69.23--70.62-
Price to Book Ratio2.99-2.63-2.37-2.20-3.96-
Price-to-Total Gains Ratio45.24-72.55-328.29-69.23--70.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.129658
Number of shares885
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (885 shares)7.85-1.83
Gains per Year (885 shares)31.38-7.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1725218-15-17
213495216-31-24
320748324-46-31
4279911433-62-38
53412314541-77-45
64014817649-93-52
74717320757-108-59
85419723865-124-66
96122226973-139-73
106724630081-155-80

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%23.015.02.057.5%33.015.02.066.0%
Book Value Change Per Share3.01.00.075.0%4.08.00.033.3%9.011.00.045.0%26.014.00.065.0%35.015.00.070.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%49.00.01.098.0%
Total Gains per Share3.01.00.075.0%5.07.00.041.7%10.010.00.050.0%27.013.00.067.5%36.014.00.072.0%

Fundamentals of Shanxi C&Y Pharmaceutical Group Co Ltd

About Shanxi C&Y Pharmaceutical Group Co Ltd

ShanXi C&Y Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of medicine and health food products. It offers anti-infective drugs, anti-allergic drugs, respiratory system drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, antidepressants, medicines, pharmaceutical raw materials, and intermediates, etc. The company's product portfolio includes Fosfomycin tromethamine powder, Mezlocillin sodium sulbactam sodium for injection, Ebastine tablets, Tamsulosin hydrochloride sustained release capsules, Cinacalcet hydrochloride tablets, Apixaban tablets, Rivaroxaban tablets, Flouxetine hydrochloride capsules, Ambroxol hydrochloride dispersible tablets, Smectite powder, Vitamin AD drops, and Baoling Yunbao oral liquid, as well as provides DNA gene preservation services. It also provides medical and health services and commercial services, such as medical diagnosis, gene preservation, and pregnancy environment testing services. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to Shanxi C&Y Pharmaceutical Group Co., Ltd. in September 2014. Shanxi C&Y Pharmaceutical Group Co., LTD. was founded in 2005 and is headquartered in Datong, China.

Fundamental data was last updated by Penke on 2024-04-16 13:34:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shanxi C&Y Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shanxi C&Y Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 17.1% means that ¥0.17 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 17.1%. The company is making a huge profit. +2
  • The TTM is 2.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ17.1%TTM2.2%+14.9%
TTM2.2%YOY-14.9%+17.1%
TTM2.2%5Y-10.7%+12.9%
5Y-10.7%10Y-3.5%-7.2%
1.1.2. Return on Assets

Shows how efficient Shanxi C&Y Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.7% Return on Assets means that Shanxi C&Y Pharmaceutical Group Co Ltd generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 2.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM0.5%+2.2%
TTM0.5%YOY-1.9%+2.4%
TTM0.5%5Y-1.2%+1.7%
5Y-1.2%10Y-0.4%-0.9%
1.1.3. Return on Equity

Shows how efficient Shanxi C&Y Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.5% Return on Equity means Shanxi C&Y Pharmaceutical Group Co Ltd generated ¥0.06 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 6.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 1.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ6.5%TTM1.0%+5.5%
TTM1.0%YOY-5.0%+6.0%
TTM1.0%5Y-3.3%+4.3%
5Y-3.3%10Y-1.2%-2.1%

1.2. Operating Efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shanxi C&Y Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Shanxi C&Y Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.5%+0.5%
TTM-0.5%YOY0.6%-1.0%
TTM-0.5%5Y-4.4%+3.9%
5Y-4.4%10Y-2.0%-2.4%
1.2.2. Operating Ratio

Measures how efficient Shanxi C&Y Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.24 means that the operating costs are ¥1.24 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 1.238. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.281. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.238TTM1.281-0.043
TTM1.281YOY1.319-0.038
TTM1.2815Y1.338-0.057
5Y1.33810Y0.876+0.463

1.3. Liquidity of Shanxi C&Y Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shanxi C&Y Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.96 means the company has ¥0.96 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 0.963. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.936. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.963TTM0.936+0.027
TTM0.936YOY1.188-0.252
TTM0.9365Y1.273-0.337
5Y1.27310Y0.743+0.530
1.3.2. Quick Ratio

Measures if Shanxi C&Y Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.26 means the company can pay off ¥0.26 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.184. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.184+0.071
TTM0.184YOY0.304-0.120
TTM0.1845Y0.450-0.266
5Y0.45010Y0.586-0.136

1.4. Solvency of Shanxi C&Y Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shanxi C&Y Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.46 means that Shanxi C&Y Pharmaceutical Group Co Ltd assets are financed with 45.7% credit (debt) and the remaining percentage (100% - 45.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 0.457. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.522. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.457TTM0.522-0.066
TTM0.522YOY0.511+0.011
TTM0.5225Y0.483+0.040
5Y0.48310Y0.407+0.076
1.4.2. Debt to Equity Ratio

Measures if Shanxi C&Y Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 109.1% means that company has ¥1.09 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The MRQ is 1.091. The company is able to pay all its debts with equity. +1
  • The TTM is 1.437. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.091TTM1.437-0.346
TTM1.437YOY1.307+0.130
TTM1.4375Y1.194+0.243
5Y1.19410Y0.893+0.300

2. Market Valuation of Shanxi C&Y Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanxi C&Y Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shanxi C&Y Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 14.96 means the investor is paying ¥14.96 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The EOD is 12.706. Based on the earnings, the company is underpriced. +1
  • The MRQ is 14.959. Based on the earnings, the company is underpriced. +1
  • The TTM is 6.552. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD12.706MRQ14.959-2.252
MRQ14.959TTM6.552+8.407
TTM6.552YOY-142.994+149.545
TTM6.5525Y-13.752+20.303
5Y-13.75210Y80.439-94.190
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The EOD is 45.728. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 53.834. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is -12.898. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD45.728MRQ53.834-8.106
MRQ53.834TTM-12.898+66.732
TTM-12.898YOY6.996-19.894
TTM-12.8985Y15.509-28.407
5Y15.50910Y331.130-315.621
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shanxi C&Y Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shanxi C&Y Pharmaceutical Group Co Ltd:

  • The EOD is 2.539. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.989. Based on the equity, the company is underpriced. +1
  • The TTM is 2.633. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.539MRQ2.989-0.450
MRQ2.989TTM2.633+0.357
TTM2.633YOY2.371+0.261
TTM2.6335Y2.203+0.430
5Y2.20310Y3.958-1.755
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shanxi C&Y Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2010.050+298%-0.015+108%-0.032+116%0.001+17100%
Book Value Per Share--3.2223.055+5%3.220+0%3.509-8%3.594-10%
Current Ratio--0.9630.936+3%1.188-19%1.273-24%0.743+30%
Debt To Asset Ratio--0.4570.522-13%0.511-11%0.483-5%0.407+12%
Debt To Equity Ratio--1.0911.437-24%1.307-17%1.194-9%0.893+22%
Dividend Per Share--0.0120.014-11%0.012-2%0.017-27%0.036-66%
Eps--0.1610.006+2787%-0.049+130%-0.081+150%-0.027+117%
Free Cash Flow Per Share--0.0450.004+1009%0.050-10%0.023+95%-0.001+101%
Free Cash Flow To Equity Per Share--0.0450.043+3%0.208-78%0.050-10%0.090-50%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.950+5%
Intrinsic Value_10Y_max--8.709--------
Intrinsic Value_10Y_min---3.863--------
Intrinsic Value_1Y_max--0.259--------
Intrinsic Value_1Y_min---0.068--------
Intrinsic Value_3Y_max--1.245--------
Intrinsic Value_3Y_min---0.482--------
Intrinsic Value_5Y_max--2.796--------
Intrinsic Value_5Y_min---1.197--------
Market Cap1976443485.440-18%2326791047.0401948053252.000+19%1833888270.720+27%1841016031.456+26%3358866639.712-31%
Net Profit Margin--0.1710.022+665%-0.149+187%-0.107+162%-0.035+120%
Operating Margin----0.0050%0.006-100%-0.0440%-0.0200%
Operating Ratio--1.2381.281-3%1.319-6%1.338-7%0.876+41%
Pb Ratio2.539-18%2.9892.633+14%2.371+26%2.203+36%3.958-24%
Pe Ratio12.706-18%14.9596.552+128%-142.994+1056%-13.752+192%80.439-81%
Price Per Share8.180-18%9.6308.063+19%7.590+27%7.620+26%13.902-31%
Price To Free Cash Flow Ratio45.728-18%53.834-12.898+124%6.996+669%15.509+247%331.130-84%
Price To Total Gains Ratio38.428-18%45.24072.552-38%328.293-86%69.227-35%-70.616+256%
Quick Ratio--0.2550.184+39%0.304-16%0.450-43%0.586-56%
Return On Assets--0.0270.005+449%-0.019+169%-0.012+146%-0.004+113%
Return On Equity--0.0650.010+552%-0.050+177%-0.033+152%-0.012+119%
Total Gains Per Share--0.2130.064+232%-0.003+101%-0.015+107%0.038+467%
Usd Book Value--107501467.047101950812.268+5%107446799.694+0%117082480.839-8%119927886.942-10%
Usd Book Value Change Per Share--0.0280.007+298%-0.002+108%-0.004+116%0.000+17100%
Usd Book Value Per Share--0.4450.422+5%0.445+0%0.485-8%0.496-10%
Usd Dividend Per Share--0.0020.002-11%0.002-2%0.002-27%0.005-66%
Usd Eps--0.0220.001+2787%-0.007+130%-0.011+150%-0.004+117%
Usd Free Cash Flow--1492231.304134580.709+1009%1660367.479-10%764637.538+95%-17261.335+101%
Usd Free Cash Flow Per Share--0.0060.001+1009%0.007-10%0.003+95%0.000+101%
Usd Free Cash Flow To Equity Per Share--0.0060.006+3%0.029-78%0.007-10%0.012-50%
Usd Market Cap272946845.339-18%321329843.596269026154.101+19%253259970.186+27%254244313.944+26%463859482.944-31%
Usd Price Per Share1.130-18%1.3301.113+19%1.048+27%1.052+26%1.920-31%
Usd Profit--5370324.182869877.644+517%-4093789.594+176%-3051231.645+157%-1067626.838+120%
Usd Revenue--31399233.44427596008.694+14%28621123.308+10%31338694.970+0%30028608.372+5%
Usd Total Gains Per Share--0.0290.009+232%0.000+101%-0.002+107%0.005+467%
 EOD+4 -4MRQTTM+27 -7YOY+20 -155Y+20 -1410Y+21 -14

3.2. Fundamental Score

Let's check the fundamental score of Shanxi C&Y Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.706
Price to Book Ratio (EOD)Between0-12.539
Net Profit Margin (MRQ)Greater than00.171
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.255
Current Ratio (MRQ)Greater than10.963
Debt to Asset Ratio (MRQ)Less than10.457
Debt to Equity Ratio (MRQ)Less than11.091
Return on Equity (MRQ)Greater than0.150.065
Return on Assets (MRQ)Greater than0.050.027
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Shanxi C&Y Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.012
Ma 20Greater thanMa 509.332
Ma 50Greater thanMa 1008.477
Ma 100Greater thanMa 2009.026
OpenGreater thanClose7.850
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,433,075
Total Liabilities654,643
Total Stockholder Equity600,133
 As reported
Total Liabilities 654,643
Total Stockholder Equity+ 600,133
Total Assets = 1,433,075

Assets

Total Assets1,433,075
Total Current Assets406,549
Long-term Assets1,026,527
Total Current Assets
Cash And Cash Equivalents 132,004
Net Receivables 107,802
Inventory 120,831
Other Current Assets 15,462
Total Current Assets  (as reported)406,549
Total Current Assets  (calculated)376,099
+/- 30,450
Long-term Assets
Property Plant Equipment 297,520
Goodwill 316,254
Intangible Assets 208,796
Long-term Assets Other 5,990
Long-term Assets  (as reported)1,026,527
Long-term Assets  (calculated)828,561
+/- 197,966

Liabilities & Shareholders' Equity

Total Current Liabilities422,366
Long-term Liabilities232,277
Total Stockholder Equity600,133
Total Current Liabilities
Short Long Term Debt 67,432
Accounts payable 36,790
Other Current Liabilities 9,536
Total Current Liabilities  (as reported)422,366
Total Current Liabilities  (calculated)113,757
+/- 308,609
Long-term Liabilities
Long term Debt 139,900
Capital Lease Obligations Min Short Term Debt18,885
Long-term Liabilities Other 6,717
Long-term Liabilities  (as reported)232,277
Long-term Liabilities  (calculated)165,503
+/- 66,774
Total Stockholder Equity
Total Stockholder Equity (as reported)600,133
Total Stockholder Equity (calculated)0
+/- 600,133
Other
Capital Stock241,619
Common Stock Shares Outstanding 241,619
Net Debt 75,328
Net Invested Capital 807,464
Net Working Capital -15,818
Property Plant and Equipment Gross 594,068



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302010-12-312009-12-312008-12-31
> Total Assets 
224,154
259,509
280,838
303,339
686,493
702,565
716,935
795,481
813,388
827,159
783,161
762,334
874,119
1,090,371
1,069,022
1,025,960
1,053,418
1,181,338
1,136,741
1,142,093
1,197,136
1,308,431
1,342,938
1,456,922
1,391,257
1,432,590
1,462,222
1,527,194
1,588,760
1,518,593
1,479,244
1,487,604
1,483,123
1,495,710
1,455,251
1,419,963
1,559,986
1,802,029
1,895,651
1,890,865
1,908,960
1,800,519
1,744,409
1,683,535
1,640,619
1,526,809
1,530,572
1,597,546
1,648,940
1,584,408
1,644,517
1,672,336
1,470,727
1,433,075
1,433,0751,470,7271,672,3361,644,5171,584,4081,648,9401,597,5461,530,5721,526,8091,640,6191,683,5351,744,4091,800,5191,908,9601,890,8651,895,6511,802,0291,559,9861,419,9631,455,2511,495,7101,483,1231,487,6041,479,2441,518,5931,588,7601,527,1941,462,2221,432,5901,391,2571,456,9221,342,9381,308,4311,197,1361,142,0931,136,7411,181,3381,053,4181,025,9601,069,0221,090,371874,119762,334783,161827,159813,388795,481716,935702,565686,493303,339280,838259,509224,154
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
576,782
583,396
634,862
602,486
604,821
752,814
648,184
593,717
591,344
613,071
578,909
532,649
493,385
469,561
375,891
394,087
462,771
523,907
508,026
576,327
595,666
451,393
406,549
406,549451,393595,666576,327508,026523,907462,771394,087375,891469,561493,385532,649578,909613,071591,344593,717648,184752,814604,821602,486634,862583,396576,7820000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114,214
131,661
147,685
106,416
115,342
225,271
143,349
173,746
145,564
193,960
188,437
154,849
155,966
142,685
107,255
120,370
199,720
272,252
263,946
343,319
358,924
140,607
132,004
132,004140,607358,924343,319263,946272,252199,720120,370107,255142,685155,966154,849188,437193,960145,564173,746143,349225,271115,342106,416147,685131,661114,2140000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,000
14,000
0
0
8,000
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000005,0008,0000014,00016,00000000000000000000000000000000000000
       Net Receivables 
79,424
15,036
7,108
16,843
29,516
48,624
44,671
113,461
119,541
135,052
131,153
103,502
87,406
127,204
110,068
108,769
118,244
140,693
127,940
147,718
148,874
185,030
161,484
231,691
250,514
259,281
322,294
354,164
294,319
308,399
346,605
320,448
317,530
315,596
254,188
237,565
259,728
338,407
249,305
262,871
247,765
235,580
211,153
183,874
179,981
142,760
127,044
122,568
125,492
101,377
84,473
99,786
92,780
107,802
107,80292,78099,78684,473101,377125,492122,568127,044142,760179,981183,874211,153235,580247,765262,871249,305338,407259,728237,565254,188315,596317,530320,448346,605308,399294,319354,164322,294259,281250,514231,691161,484185,030148,874147,718127,940140,693118,244108,769110,068127,20487,406103,502131,153135,052119,541113,46144,67148,62429,51616,8437,10815,03679,424
       Other Current Assets 
2,658
2,974
2,443
3,797
2,645
31,776
3,859
22,913
26,119
932
2,455
2,753
3,190
2,558
1,325
3,958
3,539
6,879
24,279
4,666
7,100
7,411
8,231
21,013
25,822
19,566
22,458
59,085
22,710
14,512
17,021
27,675
30,626
40,657
40,198
14,095
10,275
27,383
36,264
27,414
29,300
32,452
38,463
19,895
18,102
17,491
29,841
18,499
16,439
3,251
2,936
13,759
6,542
15,462
15,4626,54213,7592,9363,25116,43918,49929,84117,49118,10219,89538,46332,45229,30027,41436,26427,38310,27514,09540,19840,65730,62627,67517,02114,51222,71059,08522,45819,56625,82221,0138,2317,4117,1004,66624,2796,8793,5393,9581,3252,5583,1902,7532,45593226,11922,9133,85931,7762,6453,7972,4432,9742,658
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
852,766
815,142
807,172
1,153,845
1,301,934
1,299,521
1,295,889
1,221,609
1,211,760
1,190,150
1,171,058
1,150,918
1,136,485
1,134,775
1,125,032
1,076,381
1,068,190
1,076,670
1,019,334
1,026,527
1,026,5271,019,3341,076,6701,068,1901,076,3811,125,0321,134,7751,136,4851,150,9181,171,0581,190,1501,211,7601,221,6091,295,8891,299,5211,301,9341,153,845807,172815,142852,7660000000000000000000000000000000000
       Property Plant Equipment 
73,509
68,953
108,176
121,273
126,485
137,415
128,061
163,349
140,161
171,656
151,506
169,439
170,947
511,708
462,733
415,509
420,914
364,040
361,055
340,148
341,053
347,789
342,072
349,370
345,395
353,836
367,569
370,503
390,552
397,396
394,343
398,579
391,399
389,694
380,286
374,808
369,925
363,833
402,581
396,736
401,507
398,676
395,774
389,116
385,222
386,140
380,244
374,637
373,834
356,417
347,251
340,264
301,805
297,520
297,520301,805340,264347,251356,417373,834374,637380,244386,140385,222389,116395,774398,676401,507396,736402,581363,833369,925374,808380,286389,694391,399398,579394,343397,396390,552370,503367,569353,836345,395349,370342,072347,789341,053340,148361,055364,040420,914415,509462,733511,708170,947169,439151,506171,656140,161163,349128,061137,415126,485121,273108,17668,95373,509
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160,682
160,682
160,682
235,510
235,510
235,510
235,510
225,826
225,826
238,047
238,047
216,976
216,976
216,976
216,976
205,864
205,864
205,864
205,864
164,664
164,664
164,664
164,664
142,545
416,072
417,886
417,886
359,533
359,533
359,533
359,533
339,933
339,933
339,933
339,933
320,354
320,354
320,354
320,354
316,254
316,254320,354320,354320,354320,354339,933339,933339,933339,933359,533359,533359,533359,533417,886417,886416,072142,545164,664164,664164,664164,664205,864205,864205,864205,864216,976216,976216,976216,976238,047238,047225,826225,826235,510235,510235,510235,510160,682160,682160,68200000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81,712
81,119
79,778
80,138
51,851
51,551
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000051,55151,85180,13879,77881,11981,7120000000000000000000000000000000
       Intangible Assets 
26,884
30,693
24,813
39,129
38,334
21,350
68,255
62,370
201,893
47,338
179,063
43,161
191,658
48,799
253,579
250,590
247,649
316,671
313,195
322,936
318,819
307,013
318,109
376,835
372,098
346,566
341,874
337,314
333,112
317,567
312,786
102,645
97,974
93,812
124,553
81,964
120,403
120,247
299,458
296,841
293,293
258,376
256,267
236,726
234,905
235,231
231,868
229,089
226,558
222,628
222,871
221,059
211,977
208,796
208,796211,977221,059222,871222,628226,558229,089231,868235,231234,905236,726256,267258,376293,293296,841299,458120,247120,40381,964124,55393,81297,974102,645312,786317,567333,112337,314341,874346,566372,098376,835318,109307,013318,819322,936313,195316,671247,649250,590253,57948,799191,65843,161179,06347,338201,89362,37068,25521,35038,33439,12924,81330,69326,884
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
305
373
561
1,504
955
5,495
403,475
8,295
2,210
9,841
3,186
5,694
2,100
8,981
5,464
926
2,246
11,916
4,005
5,990
5,9904,00511,9162,2469265,4648,9812,1005,6943,1869,8412,2108,295403,4755,4959551,5045613733050000000000000000000000000000000000
> Total Liabilities 
117,452
141,906
131,252
130,078
108,472
121,392
130,261
162,141
172,911
175,993
125,676
108,009
215,912
323,212
297,556
250,920
263,054
358,175
305,061
472,702
325,816
435,934
463,290
525,491
450,791
477,740
499,224
561,179
619,598
547,419
498,599
545,973
536,956
564,470
511,216
457,417
597,042
869,427
920,355
946,390
878,696
927,906
883,142
848,834
814,856
782,229
787,142
759,339
848,137
854,702
911,856
960,431
740,769
654,643
654,643740,769960,431911,856854,702848,137759,339787,142782,229814,856848,834883,142927,906878,696946,390920,355869,427597,042457,417511,216564,470536,956545,973498,599547,419619,598561,179499,224477,740450,791525,491463,290435,934325,816472,702305,061358,175263,054250,920297,556323,212215,912108,009125,676175,993172,911162,141130,261121,392108,472130,078131,252141,906117,452
   > Total Current Liabilities 
77,452
121,906
131,252
130,078
108,472
121,392
130,261
154,867
165,912
169,268
119,229
101,839
120,019
207,824
167,651
127,536
139,756
232,288
179,890
364,194
283,012
262,627
290,631
344,000
270,632
328,937
339,655
424,160
447,882
476,253
409,665
466,294
407,171
398,552
350,924
310,580
355,682
393,214
439,460
471,250
446,773
489,899
445,842
421,943
436,024
400,029
397,813
368,640
316,098
599,678
666,670
572,236
515,779
422,366
422,366515,779572,236666,670599,678316,098368,640397,813400,029436,024421,943445,842489,899446,773471,250439,460393,214355,682310,580350,924398,552407,171466,294409,665476,253447,882424,160339,655328,937270,632344,000290,631262,627283,012364,194179,890232,288139,756127,536167,651207,824120,019101,839119,229169,268165,912154,867130,261121,392108,472130,078131,252121,90677,452
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71,200
71,200
31,200
119,000
79,000
99,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000099,00079,000119,00031,20071,20071,2000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71,200
71,200
31,200
119,000
79,000
99,000
99,156
164,177
163,150
81,104
100,531
79,205
82,086
82,062
91,032
92,057
90,750
87,734
57,672
58,672
60,667
75,872
67,432
67,43275,87260,66758,67257,67287,73490,75092,05791,03282,06282,08679,205100,53181,104163,150164,17799,15699,00079,000119,00031,20071,20071,2000000000000000000000000000000000
       Accounts payable 
28,348
34,147
37,116
38,364
35,467
47,374
27,091
32,706
27,881
23,527
20,272
26,791
31,806
37,107
34,059
33,759
36,710
43,658
37,346
51,876
52,312
50,329
41,105
59,342
56,863
52,398
50,390
78,005
97,067
85,411
52,530
71,329
51,971
68,709
74,306
70,265
72,489
69,096
64,091
57,562
61,066
68,218
72,897
53,625
51,598
47,355
49,560
44,574
39,826
40,889
45,984
43,942
40,928
36,790
36,79040,92843,94245,98440,88939,82644,57449,56047,35551,59853,62572,89768,21861,06657,56264,09169,09672,48970,26574,30668,70951,97171,32952,53085,41197,06778,00550,39052,39856,86359,34241,10550,32952,31251,87637,34643,65836,71033,75934,05937,10731,80626,79120,27223,52727,88132,70627,09147,37435,46738,36437,11634,14728,348
       Other Current Liabilities 
49,104
47,759
34,136
31,714
33,005
34,018
33,170
44,661
60,531
68,241
68,957
75,048
68,213
117,717
100,592
93,777
103,046
128,631
82,544
170,318
148,700
160,297
97,526
116,657
103,768
128,539
104,265
146,155
160,815
180,842
185,973
101,726
146,592
70,036
36,200
41,860
36,860
124,067
199,819
143,801
292,106
163,534
147,394
148,102
152,396
140,095
141,468
82,290
153,818
7,342
551,263
390,032
2,930
9,536
9,5362,930390,032551,2637,342153,81882,290141,468140,095152,396148,102147,394163,534292,106143,801199,819124,06736,86041,86036,20070,036146,592101,726185,973180,842160,815146,155104,265128,539103,768116,65797,526160,297148,700170,31882,544128,631103,04693,777100,592117,71768,21375,04868,95768,24160,53144,66133,17034,01833,00531,71434,13647,75949,104
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160,292
146,837
241,360
476,212
480,895
475,140
431,923
438,008
437,300
426,891
378,832
382,200
389,329
390,699
532,039
255,024
245,186
388,196
224,991
232,277
232,277224,991388,196245,186255,024532,039390,699389,329382,200378,832426,891437,300438,008431,923475,140480,895476,212241,360146,837160,2920000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
1
1
0
0
0
1,930
16,625
16,607
16,555
30,235
29,964
16,467
16,439
17,411
17,383
28,282
28,113
12,945
12,782
12,588
12,395
7,200
5,845
38,979
39,085
38,319
37,692
37,997
37,520
258,128
325,815
309,529
320,603
331,448
339,130
333,448
340,369
343,219
350,535
358,537
365,453
0
0
208,691
0
0
00208,69100365,453358,537350,535343,219340,369333,448339,130331,448320,603309,529325,815258,12837,52037,99737,69238,31939,08538,9795,8457,20012,39512,58812,78212,94528,11328,28217,38317,41116,43916,46729,96430,23516,55516,60716,6251,9300001100000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,332
22,806
33,634
36,073
35,904
36,601
32,345
24,407
21,142
21,044
5,006
6,771
7,691
9,109
15,666
15,988
16,978
18,295
0
0
17,054
0
0
0017,0540018,29516,97815,98815,6669,1097,6916,7715,00621,04421,14224,40732,34536,60135,90436,07333,63422,80622,3320000000000000000000000000000000
> Total Stockholder Equity
106,702
117,602
149,586
173,261
578,020
581,172
586,674
583,147
587,543
596,269
601,480
596,419
603,162
610,002
616,827
616,418
627,990
637,619
644,906
588,041
793,383
785,998
792,626
797,354
806,406
808,655
815,036
819,485
822,151
819,586
826,903
809,258
813,698
799,092
818,956
837,057
838,529
815,886
772,236
740,656
825,739
687,099
688,118
680,188
675,456
589,406
587,865
670,670
668,124
574,937
572,764
550,778
561,208
600,133
600,133561,208550,778572,764574,937668,124670,670587,865589,406675,456680,188688,118687,099825,739740,656772,236815,886838,529837,057818,956799,092813,698809,258826,903819,586822,151819,485815,036808,655806,406797,354792,626785,998793,383588,041644,906637,619627,990616,418616,827610,002603,162596,419601,480596,269587,543583,147586,674581,172578,020173,261149,586117,602106,702
   Common Stock
100,000
100,000
100,000
100,000
133,800
133,800
133,800
133,800
133,800
133,800
133,800
133,800
133,800
133,800
133,800
133,800
133,800
133,800
133,800
160,560
173,590
173,590
173,590
173,590
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
208,308
227,971
227,971
227,971
227,971
227,971
227,971
227,971
241,619
241,619
0
0
241,619
0
0
00241,61900241,619241,619227,971227,971227,971227,971227,971227,971227,971208,308208,308208,308208,308208,308208,308208,308208,308208,308208,308208,308208,308208,308208,308208,308208,308173,590173,590173,590173,590160,560133,800133,800133,800133,800133,800133,800133,800133,800133,800133,800133,800133,800133,800133,800133,800100,000100,000100,000100,000
   Retained Earnings 
3,183
11,193
29,426
53,101
61,618
61,236
66,738
63,211
67,606
74,838
80,049
74,988
81,731
86,363
105,121
104,711
116,283
125,913
133,199
131,551
142,818
135,433
142,061
146,786
155,827
156,901
163,294
167,795
170,468
168,159
175,476
175,150
179,591
164,985
169,202
187,303
188,775
181,772
138,122
106,542
58,044
-80,596
-79,577
-84,714
-85,983
-172,033
-173,574
-194,859
-197,405
-308,545
-310,718
-314,752
-322,274
-283,350
-283,350-322,274-314,752-310,718-308,545-197,405-194,859-173,574-172,033-85,983-84,714-79,577-80,59658,044106,542138,122181,772188,775187,303169,202164,985179,591175,150175,476168,159170,468167,795163,294156,901155,827146,786142,061135,433142,818131,551133,199125,913116,283104,711105,12186,36381,73174,98880,04974,83867,60663,21166,73861,23661,61853,10129,42611,1933,183
   Capital Surplus 000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue799,305
Cost of Revenue-257,473
Gross Profit541,832541,832
 
Operating Income (+$)
Gross Profit541,832
Operating Expense-762,978
Operating Income36,327-221,146
 
Operating Expense (+$)
Research Development49,970
Selling General Administrative364,230
Selling And Marketing Expenses0
Operating Expense762,978414,201
 
Net Interest Income (+$)
Interest Income3,743
Interest Expense-33,159
Other Finance Cost-134
Net Interest Income-29,550
 
Pretax Income (+$)
Operating Income36,327
Net Interest Income-29,550
Other Non-Operating Income Expenses0
Income Before Tax (EBT)55,27936,327
EBIT - interestExpense = -33,159
25,196
58,354
Interest Expense33,159
Earnings Before Interest and Taxes (EBIT)088,438
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax55,279
Tax Provision-6,553
Net Income From Continuing Ops48,72648,726
Net Income25,196
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net029,550
 

Technical Analysis of Shanxi C&Y Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanxi C&Y Pharmaceutical Group Co Ltd. The general trend of Shanxi C&Y Pharmaceutical Group Co Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanxi C&Y Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanxi C&Y Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.65 < 11.60.

The bearish price targets are: 7.01 > 4.98.

Tweet this
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanxi C&Y Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current macd is -0.20772208.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanxi C&Y Pharmaceutical Group Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shanxi C&Y Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shanxi C&Y Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current adx is 26.29.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shanxi C&Y Pharmaceutical Group Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanxi C&Y Pharmaceutical Group Co Ltd. The current sar is 10.81.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current rsi is 43.01. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanxi C&Y Pharmaceutical Group Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shanxi C&Y Pharmaceutical Group Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current cci is -97.0254293.

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current cmo is -20.79769207.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanxi C&Y Pharmaceutical Group Co Ltd. The current willr is -87.46803069.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Williams %R ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanxi C&Y Pharmaceutical Group Co Ltd.

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current atr is 0.74978524.

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current obv is 65,486,085.

Shanxi C&Y Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanxi C&Y Pharmaceutical Group Co Ltd. The current mfi is 49.20.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Shanxi C&Y Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartShanxi C&Y Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanxi C&Y Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Shanxi C&Y Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanxi C&Y Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.012
Ma 20Greater thanMa 509.332
Ma 50Greater thanMa 1008.477
Ma 100Greater thanMa 2009.026
OpenGreater thanClose7.850
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shanxi C&Y Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shanxi C&Y Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanxi C&Y Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanxi C&Y Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Shanxi C&Y Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shanxi C&Y Pharmaceutical Group Co Ltd.

Receive notifications about Shanxi C&Y Pharmaceutical Group Co Ltd in your mailbox!